Top 50 Medical Device Startup Investors in Asia in November 2024

Investor	Medical Device Asia investments
Cowin Capital	11
Qiming Venture Partners	11
HongShan	11
CD Capital	10
Lilly Asia Ventures	9
Haibang Capital	8
Shunwei Capital	7
BioTrack Capital	7
Med-Fine Capital	7
IDG Capital	7
Legend Capital	7
Addor Capital	6
Nippon Venture Capital	6
UntroD Capital	6
Dalton Venture	6
Marathon Venture Partners	5
SZHTI Group	5
Apricot Capital	5
Taiyu Investment	5
Mitsubishi UFJ Capital	5
Sunland Fund	5
SND Ventures Group	5
BIOCHING CAPITAL	5
BioVenture	5
Nissay Capital	5
Goldport Capital	5
Prox Ventures	4
Fortune Venture Capital	4
Taiyu Investment	4
Qiaojing Capital	4
Frees Fund	4
ASBV	4
NUS Enterprise	4
UTokyo Innovation Platform	4
Seeds Capital	4
Oriza Holdings	4
Share Capital	4
EFung Capital	4
Highlight Capital	4
Insight Capital	4
CDH Investments	4
Oriental Fortune Capital	3
Chiron Ventures	3
Yuanhui Chuangyi	3
CEJ Capital	3
Prosperico Ventures	3
Cenova	3
SBI Investment	3
Yunnan Botanee Bio Technology Group	3
Northern Light Venture Capital	3

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Apex Laser — Apex Laser is a company that focused on the research and development of semiconductor laser equipment that offers laser processing solutions for materials that are ultra-thin, ultra-hard, brittle, flexible, or composite.
Shensi Technology — Shensi Technology is a developer of current and position sensors, which are used in automobiles, new energy, and energy storage.
Xingchen Optoelectronics — Xingchen Optoelectronics is dedicated to pushing the boundaries of existing laser communication payload solutions and fostering the development of high-speed satellite laser communication networks.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
RD Technologies — RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Chimagen Biosciences — Chimagen Biosciences is a company that is creating a novel class of multi-functional monoclonal antibodies for cancer therapy.
Positive Sequence Biology — Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Angel, Series B
China

Portfolio highlights

MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.

Investment focus

Manufacturing, Internet, Software
Series A, Series B, Series C
China, India, United States

Portfolio highlights

Mihuo Intelligence — Mihuo Smart is a smart-home and appliance firm.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Zhuling Technology — Zhuling Technology is a robotics company that specializes in construction robot machines and core hardware and technology solutions.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
Puju Biotechnology — PuJu Biotech focuses on developing an engineering process platform for bioactive filling materials and is dedicated to continuously launching world-class high-end regenerative medicine material products to benefit the vast number of people seeking beauty, as well as providing new material solutions for medical beauty and anti-aging for all agegroups.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Xunlu AI — Xunlu AI is an innovative startup that focuses on the development of AI-powered customer service technologies. Xunlu AI provides AI intelligent customer service and sales robots to businesses in a variety of industries via highly tailored AI solutions, assisting businesses in achieving their goals of cost reduction and increased productivity.
B² Network — B² Network is a Bitcoin Layer 2 network that utilizes ZK rollup and on-chain logical gate commitment verification mechanisms. It is a supplementary network that runs on top of the Bitcoin Network. It also introduces smart contracts to Bitcoin, which could open up new possibilities for DeFi, NFTs, and derivatives.
Party Icons — Party Icons is a web3 mobile gaming platform. Its mission is to blend the social glue of party games with the intensity of extraction shooters.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Investment focus

Manufacturing, Electronics, Semiconductor
Series A, Series B, Funding Round
China, Hong Kong, United States

Portfolio highlights

Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
Zhongke Caixiang — Zhongke Caixiang is committed to delivering the most innovative high-end data acquisition tools and equipment.
Arrayed Materials — Arrayed Materials specializes in the development of thin-film materials and the application of high-throughput material preparation systems.

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Investment focus

Software, Health Care, Information Technology
Funding Round, Series A, Seed
Japan, United States

Portfolio highlights

Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Renalys Pharma — Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
Arsaga Partners — Arsaga Partners, Inc., "develop with the fastest and highest quality" as concept, is a one-stop IT system development company.- All functions necessary for IT system development such as IT strategy consulting, UX/UI consulting, planning, engineering, designing, maintenance and operations are provided through our one-stop solution.- With engineers accounting for over 90% of our company structure we can work directly with our clients. - Our motto is to providing services at a reasonable cost without outsourcing and to bring our Japanese omotenashi spirit to our development services. - We think of Digital transformation (DX) Not as a trendy word, but as IT system development that truly contributes to our clients' business needs.Main Services - One-stop IT System Development Business, Start-up/New IT Business Consulting, Enterprise System/New Business Planning and Development(Digital Transformation/DX), Web System Planning and Development, Application Planning and DevelopmentKey Clients - Nippon Steel Kowa Real Estate Co., Ltd., Mitsubishi Estate, ShionogiV-CUBE, Mizuho Securities, Sciseed inc.

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Investment focus

Manufacturing, Biotechnology, Robotics
Funding Round, Seed, Series A
Japan, Singapore, India

Portfolio highlights

Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Emulsion Flow Technologies — Emulsion Flow Technologies offers rare metal recycling, utilizing emulsion flow technology, emulsion.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Angel
China

Portfolio highlights

Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
PharMolix Inc. — Pharmolix is a biomedical company that focuses on the R&D and application of large models in the vertical industry of biomedicine.
Kangyuan Medical — Kangyuan Medical is committed to developing, and manufacturing a new generation of precise and effective blood purification adsorption materials.

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.

SZHTI Group is a company that provides asset management and financing services.

Investment focus

Manufacturing, Electronics, Semiconductor
Series A, Angel, Funding Round
China, United States

Portfolio highlights

Light Future — Light Future is a complete metal additive manufacturing solutions provider for the industrial market. It is dedicated to speeding up the global industrialization of metal additive manufacturing technology and focuses on all-inclusive solutions for industrial-grade metal additive manufacturing. This will enable additive manufacturing technology tobecome truly inclusive for industrial use.
Ruibo Automation — Ruibo Automation is a high-tech inventive firm that specializes in Press-Fit pin process automation equipment. It combines independent research and development, manufacturing, and sales.
Xiaoyao Technology — Xiaoyao Technology is an optoelectronic chip design automation.

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
China, United States, Hong Kong

Portfolio highlights

Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Simcere Pharma — Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.

Taiyu Investment is an investment firm.

Investment focus

Medical, Medical Device, Biotechnology
Series A, Angel, Seed
China

Portfolio highlights

Curegene — Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms.
Juhai Hengchuang — Juhai Hengchuang is a medical device manufacturer that exclusively sells and manufactures drug testing equipment.
St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

A-Wave — A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.
Tribeau — Tribute is a word-of-mouth app for aesthetic medicine for cosmetic surgeries, cosmetic dermatologists, and orthodontists who are not covered by health insurance.
AI model — AI model specializes in the development and transformation of real-like virtual models for modeling on E-commerce platforms.

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

Investment focus

Health Care, Manufacturing, Medical
Series A, Series B, Angel
China

Portfolio highlights

Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
Shenglei Technology — Shenglei Technology manufactures engineering products and offers laser ultrasonic testing services.
Guancheng Information — Guancheng Information is a competent provider of comprehensive intelligent industrial solutions. It focuses on the medical device and high-technology electronics industries.

BIOCHING CAPITAL is an investment management firm.

Investment focus

Medical Device, Medical, Biopharma
Angel, Seed
China

Portfolio highlights

Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Thorough Future — Using big data and artificial intelligence to provide pathology images with intelligent discriminations, diagnosis, prediction.
Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States, Ethiopia

Portfolio highlights

Tribeau — Tribute is a word-of-mouth app for aesthetic medicine for cosmetic surgeries, cosmetic dermatologists, and orthodontists who are not covered by health insurance.
Space One — Space One specializes in the production and development of rockets and offers innovative solutions for space transportation services.
Qlay — Qlay is an AI-automated global engineer hiring platform

Goldport Capital is a Shenzhen-based asset management company.

Investment focus

Manufacturing, Medical, Biopharma
Series A, Seed, Angel
China

Portfolio highlights

Fast Photonics — Fast Photonics specializes in the development and manufacturing of high-speed optical transceivers. The company offers a range of products designed for various applications in the field of optical communication. With a focus on innovation, Fast Photonics aims to provide solutions that meet the evolving needs of data transmission and communicationnetworks. The company holds ISO certification, emphasizing its commitment to quality and standards in manufacturing processes. Fast Photonics serves as an OEM/ODM/JDM partner, offering customized solutions to meet specific customer requirements. The company's expertise in optical technology makes it a key player in the industry, catering to the demands for faster and more efficient data communication.
REEM Healthcare — REEM Healthcare is a new type of medical device R&D and manufacturing company focused on the development and production of PHIS tiny particle units (professional, wearable, and implantable), new medical device IoT goods, and the provision of professional smart disease management services.Ruimeng Medical brings together senior experts in medicaldevices, health management, mobile Internet, big data processing, and other fields to form a new medical device R&D and production enterprise dedicated to the R&D and production of PHIS small particle units (professional, wearable, and implantable), new medical device IoT products, and professional intelligent disease management services.
Ruigu New Materials — Ruigu New Materials is a new energy battery technology developer that specializes in the research, development, and manufacture of new energy battery technology, as well as the research, development, and production of sulfide solid electrolytes.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Investment focus

Manufacturing, Information Technology, Health Care
Series A, Series B, Seed
China, Japan, United States

Portfolio highlights

Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
Infinigence — Wuwen Core Dome is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
Zhongke Caixiang — Zhongke Caixiang is committed to delivering the most innovative high-end data acquisition tools and equipment.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Angel
China

Portfolio highlights

Immorna — Immorna specializes in the production of RNA-based therapeutics.
ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.

Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Angel
China

Portfolio highlights

Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Medical, Biotechnology
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
Molar Intelligence — Molar Intelligence is a professional artificial intelligence data service provider.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China, Australia, Hong Kong

Portfolio highlights

Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

NUS Enterprise provides an entrepreneurial and innovative dimension to the National University of Singapore’s core research and educational activities.By encouraging the entrepreneurial spirit, partnering for success, and nurturing future entrepreneurial leaders, NUS Enterprise aims to make a positive impact on Singapore’s economy and beyond.This is done through three key thrusts: entrepreneurship support, industry engagement and partnerships, and experiential education.NUS Enterprise was founded in 2001 and is based in Singapore.

Investment focus

Information Technology, Health Care, Software
Pre-Seed, Grant, Seed
Singapore, Turkey, United States

Portfolio highlights

YoRipe — YoRipe helps household to enjoy easy, healthy, and personalized cooking while empowering real time personalized marketing for FMCGs and retailers. The mobile platform brings more efficient marketing and actual shopper behavior insights to brands and stores. YoRipe’s aim is to make managing grocery at home more pleasant and efficient to save timeand money.YoRipe gives recipes for diet, allergies, and cravings. This mobile app also tracks food and send reminders before they expire whenever and wherever.
Guardara — The most comprehensive negative testing / fuzz testing platform to hunt down bugs and zero-day vulnerabilities.
Responsible Cyber with IMMUNE — Responsible Cyber Landing Page

The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.

Investment focus

Biotechnology, Medical, Manufacturing
Series A, Funding Round, Series B
Japan, United States, United Kingdom

Portfolio highlights

OOYOO — OOYOO Co., Ltd. is a DeepTech venture that combines international entrepreneurial spirit, and a 'Made In Japan' excellence, to bring the latest innovations in clean technology to society for a smarter, cleaner, and more mobile world.
Visban — Visban is a technology company that specializes in utilizing mmWave signals for connectivity both indoors and outdoors. Their primary focus is on providing reliable and fast network solutions that eliminate dead spots and offer uninterrupted connections. By utilizing mmWave signals, Visban can achieve this with fewer base stations, leading to moreenergy-efficient operations and extended battery life for mobile devices on their network.
Trans-N — Trans-N aims to introduce advanced AI technologies, accelerating digital transformation and promoting its AI transformation. Trans-N offers management consulting, AI system development, and sales of AI-related products, including meeting minutes and contract analysis tools, serving major trading companies.

Catalysing smart monies into Singapore-based, early-stage technology startups.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Funding Round
Singapore, United States, Hong Kong

Portfolio highlights

DiMuto — DiMuto is a platform facilitating collaborative commerce that provides supply chain visibility. They provide global supply chains with a trade technology platform built on 4Ts: Tracking, Tracing, Transparency and Trust – thus demystifying global trade and enabling collaborative commerce. The DiMuto Track & Trace blockchain platform createsend-to-end trade visibility and forms building blocks for further value creation in trade financing, product marketing, and data analytics.DiMuto is founded by executive chairman Mr Gary Loh, who is also the Executive Chairman of First Alverstone Group.
Aevice Health — Meet our AeviceMD, all-in-one sensor to deliver hospital-quality insights, right from home.
Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Investment focus

Health Care, Manufacturing, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Jiongyi Electronics — Jiongyi Electronics is a developer of automotive brake products, focusing on the development of automotive brake product technology.
Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
Junhemeng Biopharmaceutical — Junhemeng is a research and development company of recombinant protein drugs.

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Angel
China, United States, Colombia

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Insight Capital is a venture capital firm focused on early-stage investment.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
China

Portfolio highlights

Social+ — Discover Amity, where we create digital solutions that help organizations, teams and individuals achieve more through technology and social innovation.
Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Yida Technology — SaaS, Data
Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

Chiron Ventures is an investment firm specializes in innovation and investment in medical health.Chiron Ventures has accumulated rich experience and resources in medical technology development, medical innovation and entrepreneurship, and medical market development, providing substantial support and professional value-added services for itsinvestment projects.

Investment focus

Medical, Health Care, Medical Device
Series A, Seed, Angel
China, Australia, United States

Portfolio highlights

Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
Ren Labs — Empowering projects to create a limitless future for the decentralized web.
Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.

Yuanhui Chuangyi is an investment firm.

Investment focus

Medical Device, Beauty, Industrial
Seed, Series A
China

Portfolio highlights

Toll PATEO — Toll PATEO is a natural science, medical research and experimental development service provider.
Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
Xijian Technology — Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology. It focuses on health disciplines such as sports rehabilitation, dermatology and beauty, and disease diagnosis and treatment.

CEJ Capital is a venture capital arm of CYBERDYNE. It engages in the creation of cybernics industry, management, and management of growth promotion investment business association property.

Investment focus

Medical, Nursing and Residential Care, Medical Device
Series A, Series B, Funding Round
Japan

Portfolio highlights

ANSeen — X-ray COLOR Imaging
GAIA BioMedicine — GAIA BioMedicine Inc., a spin-out venture from Kyushu University founded on 2015, is a technology-driven biopharmaceutical company focusing on cellular therapies and immunotherapies mainly for intractable malignancies.
Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States

Portfolio highlights

Cytocares — Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
KingstronBio — KingstronBio manufactures artificial heart valves and annuloplasty rings.
Jiaohong Biology — Jiaohong Biology is a molecular diagnostic technology research and development and application service provider.

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, Singapore, United States

Portfolio highlights

Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Investment focus

Information Technology, Software, Financial Services
Series B, Funding Round, Series A
Japan, South Korea, United States

Portfolio highlights

AironWorks — Next Gen Solutions for Human-Based Cyber Attacks
Recustomer — Recustomer is an IT company that develops software for digital payment and provides support for web development.
PartnerSuccess — PartnerSuccess develops and provides SaaS tools that automate the collaboration between manufacturers and distributors.

Yunnan Bethany Biotechnology is a healthcare company that manufactures skin care products for sensitive skin, acne, barrier damage, stubborn spots, and fragile skin. They provide a scientific care programs for certain skin problems and develop effective and safe skin care products.

Investment focus

Medical, Medical Device, Health Care
Series A, Corporate Round
China

Portfolio highlights

Weimu Medical — Weimu Medical is a high-end interventional medical device developer.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Ruishi Technology — Ruishi Technology develops Myopia prevention and control medical devices.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

RootData — Providing the most up-to-date and complete Crypto project financing information,detailed project background,team members,investors,news updates,token price data,and on-chain assets tracking. Dedicated to making Crypto investing easier.
Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
Coordinate System Intelligence — Coordinate System Intelligence is a provider of automotive brake-by-wire system solutions. It focuses on providing core technology solutions.